Particle.news
Download on the App Store
13 ARTICLES
·
1h ago

ED Raids Seven Chennai Sites Linked to Coldrif Maker and Tamil Nadu Drug Officials

The operation follows lab findings confirming lethal diethylene glycol contamination.

Image
Image
Sresan Pharma owner, S. Ranganathan, is escorted by Police to a local court after one of their medicines, Coldrif cough syrup, was linked to the death of multiple children in Parasia, Madhya Pradesh, India, October, 10, 2025. REUTERS/Priyanshu Singh
Saddam Mansuri, the father of two, shows bottles of Coldrif, linked to the deaths of several children and a Relife cough syrup, which is not linked to any deaths, but Indian authorities have asked people to avoid it, which he had been giving his one-year-old child, in Parasia, Madhya Pradesh, India, October 10, 2025. REUTERS/Priyanshu Singh

Overview

  • Enforcement Directorate teams carried out PMLA searches at seven locations in Chennai, including Sresan/Sreesan Pharma premises and the residences of senior state drug control officials.
  • The probe centers on the deaths of at least 22 children after Coldrif was administered in Madhya Pradesh, leading to bans on the syrup in multiple states.
  • Official tests reported approximately 48.6% diethylene glycol in a Tamil Nadu analysis and 46% in a Madhya Pradesh analysis of Coldrif samples.
  • Sresan owner G. Ranganathan was arrested on October 9; authorities have sealed the manufacturing unit as states ban the product and move on licence cancellation.
  • Investigators are scrutinizing company finances, distribution records and possible regulatory collusion, with potential links to other firms under examination.